Beactica Wins Grant to Develop Combination Therapy for Glioblastoma |
| June 18, 2019 | June 2019 Bond Updates |
|
STOCKHOLM, June 18, 2019 /PRNewswire/ -- Beactica AB, the Swedish drug discovery company, today announced that it has been awarded a grant of 2.8 MSEK (~$300 000) from SweLife and Medtech4Health for its project focused on finding effective therapies for glioblastoma, an aggressive form of ... |
| View more at: https://www.prnewswire.com:443/news-releases/beactica-wins-grant-to-develop-combination-therapy-for-glioblastoma-300870101.html |
| Related News |